Eosinophil granule cationic proteins: eosinophil activation markers;Les protéines cationiques de l'éosinophile : marqueurs d'activation du polynucléaire éosinophile

Revue de Medecine Interne

Volumn 27, Issue 5, 2006, Pages 406-408

  Guilpain, P ^a   Guillevin, L ^b   Mouthon, L ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Cochin   (France)

Author keywords

Allergy; Churg Strauss syndrome; Eosinophil; Eosinophil cationic protein; Eosinophil derived neurotoxin

Indexed keywords

BIOCHEMICAL MARKER; CYTOTOXIC FACTOR; EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; MAJOR BASIC PROTEIN;

ALLERGY; CELL FUNCTION; CHURG STRAUSS SYNDROME; CYTOTOXICITY; EOSINOPHIL; HELMINTHIASIS; HUMAN; PARASITOSIS; PATHOGENESIS; SHORT SURVEY;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CHURG-STRAUSS SYNDROME; CYTOPLASMIC GRANULES; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; MYELIN BASIC PROTEINS;

EID: 33646492503     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.01.008     Document Type: Short Survey

References (13)

1. Kristjansson S., Strannegard I.L., Strannegard O., Peterson C., Enander I., and Wennergren G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J. Allergy Clin. Immunol. 97 (1996) 1179-1187
2. Zimmerman B., Lanner A., Enander I., Zimmerman R.S., Peterson C.G., and Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin. Exp. Allergy 23 (1993) 564-570
3. Juntunen-Backman K., Jarvinen P., and Sorva R. Serum eosinophil cationic protein during treatment of asthma in children. J. Allergy Clin. Immunol. 92 (1993) 34-38
4. Rao R., Frederick J.M., Enander I., Gregson R.K., Warner J.A., and Warner J.O. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin. Exp. Allergy 26 (1996) 789-793
5. Noguchi E., Iwama A., Takeda K., Takeda T., Kamioka M., Ichikawa K., et al. The promoter polymorphism in the eosinophil cationic protein gene and its influence on the serum eosinophil cationic protein level. Am. J. Respir. Crit. Care Med. 167 (2003) 180-184
6. Schmekel B., Ahlner J., Malmstrom M., and Venge P. Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma. Respir. Med. 95 (2001) 670-675
7. Pizzichini M.M., Pizzichini E., Clelland L., Efthimiadis A., Mahony J., Dolovich J., et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am. J. Respir. Crit. Care Med. 155 (1997) 1501-1508
8. Schmitt W.H., Csernok E., Kobayashi S., Klinkenborg A., Reinhold-Keller E., and Gross W.L. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum. 41 (1998) 445-452
9. Morita H., Kihara T., Tatsumi Y., Kitano Y., and Sagami S. Allergic granulomatosis and angiitis of Churg-Strauss. A case of high serum level of eosinophil cationic protein. Acta Derm. Venereol. 72 (1992) 201-202
10. Cottin V., Tardy F., Gindre D., Vernet G., Deviller P., and Cordier J.F. Urinary eosinophil-derived neurotoxin in Churg-Strauss syndrome. J. Allergy Clin. Immunol. 96 (1995) 261-264
11. Tai P.C., Holt M.E., Denny P., Gibbs A.R., Williams B.D., and Spry C.J. Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br. Med. J. (Clin. Res. Ed.) 289 (1984) 400-402
12. Peen E., Hahn P., Lauwers G., Williams Jr. R.C., Gleich G., and Kephart G.M. Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum. 43 (2000) 1897-1900
13. Schnabel A., Csernok E., Braun J., and Gross W.L. Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax 54 (1999) 771-778